Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs

Blocking the enzyme Fatty Acid Synthase (FASN) leads to apoptosis of HER2-positive breast carcinoma cells. The hypothesis is that blocking FASN, in combination with anti-HER2 signaling agents, would be an effective antitumor strategy in preclinical HER2+ breast cancer models of trastuzumab and lapat...

Descripción completa

Detalles Bibliográficos
Autores principales: Blancafort, Adriana, Giró-Perafita, Ariadna, Oliveras, Glòria, Palomeras, Sònia, Turrado, Carlos, Campuzano, Òscar, Carrión-Salip, Dolors, Massaguer, Anna, Brugada, Ramon, Palafox, Marta, Gómez-Miragaya, Jorge, González-Suárez, Eva, Puig, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479882/
https://www.ncbi.nlm.nih.gov/pubmed/26107737
http://dx.doi.org/10.1371/journal.pone.0131241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479882/
https://www.ncbi.nlm.nih.gov/pubmed/26107737
http://dx.doi.org/10.1371/journal.pone.0131241

Ejemplares similares